BST

Oxford Biomedica to host webinar showcasing the TetraVecta™ system

Retrieved on: 
Thursday, September 7, 2023

Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led viral vector CDMO, today announces that it will host a webinar on the TetraVectaTM system, the Company’s 4th generation lentiviral vector delivery system, on Monday 2 October 2023.

Key Points: 
  • Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led viral vector CDMO, today announces that it will host a webinar on the TetraVectaTM system, the Company’s 4th generation lentiviral vector delivery system, on Monday 2 October 2023.
  • The webinar titled “4th Generation Lentiviral Vectors: An Improved Gene Delivery System” will feature presentations by Dr Nick Clarkson, Vice President, Head of Platform Research at Oxford Biomedica and Dr Dan Farley, Senior Director of the Vector Engineering Group at Oxford Biomedica, who will discuss how the TetraVecta™ system can significantly enhance the development and manufacturing of safer and more effective lentiviral vector-based therapies through improved quality, potency and packaging capacity.
  • The webinar will be held at 16:00 BST / 11:00 EST on Monday 2 October 2023, followed by a live Q&A session.
  • Oxford Biomedica’s TetraVectaTM system launched in May 2023 following years of development and on the basis of detailed understanding of specific industry challenges.

Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, September 7, 2023

Furthermore, we have secured a solid financial footing which allows us to press ahead toward our goal of European commercialization,” said Dario Eklund, CEO of Santhera.

Key Points: 
  • Furthermore, we have secured a solid financial footing which allows us to press ahead toward our goal of European commercialization,” said Dario Eklund, CEO of Santhera.
  • Total consideration to Santhera is up to USD 231 million (including equity investment) plus royalty payments from product sales.
  • After closing of the transaction in July 2023, Santhera received an upfront payment of USD 90 million (USD 75 million in cash and USD 15 million equity investment).
  • During the six months ending June 30, 2023, Santhera committed to the sale of Raxone/idebenone upon settlement of the French case and the transaction closed on July 28, 2023.

Ferguson to Issue Fourth Quarter and Year End Results And Host Conference Call on September 26, 2023

Retrieved on: 
Tuesday, September 12, 2023

Ferguson plc (NYSE: FERG; LSE: FERG) announces today that it will issue its fourth quarter and year end results on Tuesday, September 26.

Key Points: 
  • Ferguson plc (NYSE: FERG; LSE: FERG) announces today that it will issue its fourth quarter and year end results on Tuesday, September 26.
  • The results will be available on Ferguson’s website at corporate.ferguson.com at 6:45 a.m. ET/11:45 a.m. BST.
  • A conference call and webcast of the analyst and investor presentation will be broadcast at 8:30 a.m. ET/1:30 p.m. BST on the same day.
  • An archived version of the webcast and slide presentation will be available for 12 months after the live event.

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Retrieved on: 
Tuesday, September 12, 2023

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the J.P. Morgan 14th Annual U.S. All Stars Conference on Monday, September 18, 2023 at 11:00 a.m. BST.

Key Points: 
  • Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the J.P. Morgan 14th Annual U.S. All Stars Conference on Monday, September 18, 2023 at 11:00 a.m. BST.
  • To view and listen to the webcast, visit our web site at www.pfizer.com/investors .
  • Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.
  • The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

Analog Devices to Participate in J.P. Morgan 14th Annual U.S. All Stars Conference

Retrieved on: 
Tuesday, September 12, 2023

Analog Devices, Inc. (Nasdaq: ADI ) today announced that the Company’s Chief Executive Officer & Chair of the Board of Directors, Vincent Roche, will discuss business topics and trends at the J.P. Morgan 14th Annual U.S. All Stars Conference located in London, England on Monday, September 18, 2023, at 10:00 a.m. BST.

Key Points: 
  • Analog Devices, Inc. (Nasdaq: ADI ) today announced that the Company’s Chief Executive Officer & Chair of the Board of Directors, Vincent Roche, will discuss business topics and trends at the J.P. Morgan 14th Annual U.S. All Stars Conference located in London, England on Monday, September 18, 2023, at 10:00 a.m. BST.
  • The webcast for the conference may be accessed live via the Investor Relations section of Analog Devices’ website at investor.analog.com .
  • An archived replay will also be available following the webcast for at least 30 days.

Aramark to Participate in Upcoming Citi Investor Conference

Retrieved on: 
Friday, September 8, 2023

Aramark (NYSE:ARMK), a global leader in food, facilities management and uniforms, announced that the Company’s Chief Financial Officer, Tom Ondrof, and Chief Operating Officer, International, Carl Mittleman, will participate in Citi’s 2023 Growth Conference in London on September 15, 2023, with a featured Fireside Chat session beginning at 11:20 a.m. BST / 6:20 a.m. EDT.

Key Points: 
  • Aramark (NYSE:ARMK), a global leader in food, facilities management and uniforms, announced that the Company’s Chief Financial Officer, Tom Ondrof, and Chief Operating Officer, International, Carl Mittleman, will participate in Citi’s 2023 Growth Conference in London on September 15, 2023, with a featured Fireside Chat session beginning at 11:20 a.m. BST / 6:20 a.m. EDT.

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

Retrieved on: 
Monday, September 11, 2023

THOUSAND OAKS, Calif., Sept. 11, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 11:40 a.m. BST on Thursday, Sept. 14, 2023.

Key Points: 
  • THOUSAND OAKS, Calif., Sept. 11, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 11:40 a.m. BST on Thursday, Sept. 14, 2023.
  • Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference.
  • The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.

LyondellBasell to Address J.P. Morgan 14th Annual U.S. All Stars Conference

Retrieved on: 
Monday, September 11, 2023

HOUSTON and LONDON, Sept. 11, 2023 /PRNewswire/ -- LyondellBasell, a leader in the global chemical industry, today announced Michael McMurray, executive vice president and chief financial officer, will participate in a fireside chat at the J.P. Morgan 14th Annual U.S. All Stars Conference in London on Tuesday, September 19, 2023 at 11 a.m. BST / 6 a.m. EDT.

Key Points: 
  • HOUSTON and LONDON, Sept. 11, 2023 /PRNewswire/ -- LyondellBasell, a leader in the global chemical industry, today announced Michael McMurray, executive vice president and chief financial officer, will participate in a fireside chat at the J.P. Morgan 14th Annual U.S. All Stars Conference in London on Tuesday, September 19, 2023 at 11 a.m. BST / 6 a.m. EDT.
  • A live webcast can be accessed at the time of the event at https://www.LyondellBasell.com/en/investors/investor-events/ .
  • A replay of the event will be available at the same link within 24 hours following the webcast.

CENTENE TO PRESENT AT BANK OF AMERICA SECURITIES GLOBAL HEALTHCARE CONFERENCE 2023

Retrieved on: 
Friday, September 1, 2023

ST. LOUIS, Sept. 1, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lies, announced today it will present at the Bank of America Securities Global Healthcare Conference, to be held on Wednesday, September 13 – Thursday, September 14, 2023, in London, England.

Key Points: 
  • ST. LOUIS, Sept. 1, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lies, announced today it will present at the Bank of America Securities Global Healthcare Conference, to be held on Wednesday, September 13 – Thursday, September 14, 2023, in London, England.
  • Centene will present on at 11:40 a.m. British Summer Time (BST)/6:40 a.m. Eastern Daylight Time (EDT) on Wednesday, September 13.
  • A simultaneous live audio webcast will be available at: https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2023/idqdEvyJ.cfm .
  • A webcast replay will be available following the presentation on Centene's website, www.centene.com , under the Investors section.

2Q23 RESULTS CALL REGISTRATION AND PARTICIPATION DETAILS

Retrieved on: 
Thursday, August 31, 2023

NEW YORK, Aug. 31, 2023 /PRNewswire/ -- Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today announces registration and participation details for its results call for the three months and six months ended June 30, 2023, to be held on Wednesday, September 13, 2023, at 10.00am EDT / 3.00pm BST.

Key Points: 
  • NEW YORK, Aug. 31, 2023 /PRNewswire/ -- Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today announces registration and participation details for its results call for the three months and six months ended June 30, 2023, to be held on Wednesday, September 13, 2023, at 10.00am EDT / 3.00pm BST.
  • The dial-in number for the conference call is +1 646 787-9445 (USA) / +44 (0)20 4587 0498 (UK) / +44 (0)20 3936 2999 (all other locations) and the access code is 329784.
  • To minimize the risk of delayed access, participants are urged to dial into the conference call by 9.40am EDT / 2.40pm BST.
  • A live webcast of the call will also be available at https://www.investis-live.com/burfordcapital/6499460f383e9013000dafed/ro... , and pre-registration at that link is encouraged.